All Posts IMO. Do your own research
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good question. Not sure. The good news is there appears to be some interest and volume has been high the past week and PPS moved up a bit.
GLTA shareholders
Check out @newgcg24 on X
Interesting
Interesting volume and PPS movement.
Any AEGY news?
Very interesting volume today. Curious if there’s any news?
Interesting volume today
Pink current
PHRRF looking good. GLTA
Nice volume recently. GLTa shareholders
Looks like a new tweet update.
“EDGAR passcodes achieved! Thank you very much”
Nice move up on good volume. GLTA
Would be nice. Shareholders been waiting a long time. GLTU
BRAND + WEBSITE + BP + PR + ANNOUNCEMENT + PINK CURRENT ----》JAN. 24th DEADLINE. $NGCG pic.twitter.com/BOzGi6Vb2V
— New Generation Consumer Group Inc (@newgcg24) January 18, 2024
Seems like a few days have already passed. Hopefully this is not just nonsense.
GLTA shareholders
This is a tweet from “NGCG Official” earlier today. Hopefully they follow through
GLTA shareholders
Hopefully there’s good news soon
Would be nice. GLTA shareholders
PHRRF continuing that nice climb upwards today. GLTA shareholders
52 week high again today. GLTA shareholders
52 week high today! Nice
Interesting that PHRRF and RVVTF mentioned in the article below. GLTA
From the article below:
“In February 2023, Revive Therapeutics Ltd. entered into a research collaboration agreement with PharmaTher Holdings Ltd. to evaluate the delivery of 3,4-Methylenedioxymethamphetamine ("MDMA") using PharmaTher's novel microneedle patch ("MN-Patch") delivery technology. The MDMA MN-Patch enables flexible drug load capacity and combinations, controlled released delivery, and the ability to present desired pharmacokinetic and safety profiles, overcoming the potential obstacles of oral dosing.”
GLTA shareholders
Thoughts on XXII and recent PRs?
Would be nice. Why?
OT, the tweet on 6/22 has this:
“A new and definitive Annual Attorney Letter will be submitted in the following hours. We hope that this is the final step before getting the green light. $NGCG”
Note: The AL on OTMC is dated 6/15 and has a “published date” of 6/19. So is that the latest or were they going to submit a new one? In any case, curious what the hold up is and when they’ll be current
OT, I’m not sure they did it yet since OTCM still shows yield and pink limited info
Or maybe something else not updated?
Has this happened yet? Last I checked it was dated 6/19
22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced that it will effect a reverse stock split of its outstanding shares of common stock, par value $0.00001 per share (the “Common Stock”), at a ratio of 1-for-15, to be effective as of 12:00 a.m. Eastern Time on July 5, 2023. The reverse stock split is intended for the Company to regain compliance with the minimum bid price requirement of $1.00 per share of common stock for continued listing on Nasdaq.
Seems like there’s been a lot of recent revisions, amendments and resubmission of filings. Hopefully they got it right this time
Looking good here
Looking forward to more updates from PHRRF
Nice move up today. GLTA shareholders